Evaluation of Tuberculosis Preventive Treatment Initiation, Adherence and Completion in Country of Georgia
PDF

Keywords

latent tuberculosis
preventive treatment
contact investigation
rifapentine treatment

How to Cite

Kokhreidze, E., Zaza Avaliani, Timo Ulrichs, Hani Nasr, Maia Butsashvili, & Tamar Goderidze. (2025). Evaluation of Tuberculosis Preventive Treatment Initiation, Adherence and Completion in Country of Georgia. Caucasus Journal of Health Sciences and Public Health, 6(1), 58–71. Retrieved from https://caucasushealth.ug.edu.ge/index.php/caucasushealth/article/view/419

Abstract

Background: Latent tuberculosis infection (LTBI) treatment is essential for preventing active tuberculosis (TB) but remains underutilized in Low- and middle-income countries (LMICs). In 2020, Georgia transitioned to a three-month Rifapentine-based regimen. This study assessed the LTBI care cascade among TB contacts in Georgia (2020–2021).

Methods: A mixed-method cohort study examined TPT recommendations and completion rates among contacts of active TB cases. Study was conducted in five TB-units of Georgia (National Center for Tuberculosis and Lung Disease (NCTLD), Shida Kartli, Kvemo Kartli, Gori, Kutaisi).

Results: Among 611 contacts, 338 (55.3%) were female, and 83 (13.5%) were children under five. Tuberculosis preventive treatment (TPT) was recommended for 439 (74.5%), with 275 (65%) initiating treatment and 131 (47%) completing it. Six participants developed active tuberculosis later, who did not initiate tuberculosis preventive treatment.

Conclusions: LTBI treatment uptake in Georgia remains low, underscoring the need for improved monitoring and adherence strategies. High TB incidence in untreated contacts highlights the importance of preventive treatment.

PDF
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 Eka Kokhreidze, Zaza Avaliani, Timo Ulrichs, Hani Nasr, Maia Butsashvili, Tamar Goderidze